# To Study the Impact of Stopping Therapy in Patients of CML With Molecular Remission

> **NCT03062436** · NA · UNKNOWN · sponsor: **Command Hospital, India** · enrollment: 27 (actual)

## Conditions studied

- Chronic Myeloid Leukemia
- Treatment Free Remission

## Interventions

- **OTHER:** Stopping the standard drug therpy
- **DIAGNOSTIC_TEST:** Quantitative bcrabl recording every month for first 6 months

## Key facts

- **NCT ID:** NCT03062436
- **Lead sponsor:** Command Hospital, India
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-08-01
- **Primary completion:** 2019-12-31
- **Final completion:** 2020-12
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2019-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03062436

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03062436, "To Study the Impact of Stopping Therapy in Patients of CML With Molecular Remission". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03062436. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*